Gain an unbiased perspective of the market and its potential.
Market Dynamix™ reports blend data from specialists, patients, and leading KOLs.
- Market size and current treatment approaches
- What’s needed to support early adoption and optimization of an asset
- Unmet needs and attributes most desired in new therapeutics
- Expert opinions on the likely disruption introduced by pipeline agents
Methodology:
- Insights are based on analyses of quantitative data from an online survey of specialists, patients, and leading KOLs recruited from the Spherix Network, as well as qualitative interviews with a subset of survey respondents and select KOLs
Sample Size & Frequency: